AAOS: Thrombin-based hemostatic reduces blood loss, but not haemoglobin loss, in TKA
Prospective, Randomized Trial to Evaluate Effectiveness of a Thrombin-Based Hemostatic in Total Knee Arthroplasty
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
108 patients undergoing primary unilateral total knee arthroplasty (TKA) were randomized to receive either a thrombin-based topical hemostatic matrix sealant with electrocautery or electrocautery alone. The purpose of this study was to determine whether this hemostatic agent is effective for reducing blood loss and transfusion rates. Results indicated that the use of the hemostatic agent was assoc...
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.Continue